Evidence map›Paper›PMID 41808080›Full record

ArticleBMC health services research2026

Assessing vaccine cold chain storage and transport in Ukraine: a cross-sectional study.

Stanislav Gaievskyi, Yevgenii Grechukha, Oleg Khomenko, Nasrin Musa Widaa Musa, Oleg Benes, Jarno Habicht, Oleksandr Zaika, Ihor Starychenko, Ihor Kizin

Abstract read
In one paragraph

Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Stanislav GaievskyiWHO Country Office in Ukraine, Mykhaila Hrushevskoho St, 9B, Kyiv, 01021, Ukraine. gaievskyis@who.int.
Yevgenii GrechukhaWHO Country Office in Ukraine, Mykhaila Hrushevskoho St, 9B, Kyiv, 01021, Ukraine.
Oleg KhomenkoWHO Country Office in Ukraine, Mykhaila Hrushevskoho St, 9B, Kyiv, 01021, Ukraine.
Nasrin Musa Widaa MusaWHO Regional Office for Europe, UN City Marmorvej 51, Copenhagen Ø, DK-2100, Denmark.
Oleg BenesWHO Regional Office for Europe, UN City Marmorvej 51, Copenhagen Ø, DK-2100, Denmark.
Jarno HabichtWHO Country Office in Ukraine, Mykhaila Hrushevskoho St, 9B, Kyiv, 01021, Ukraine.
Oleksandr ZaikaMinistry of Health of Ukraine, Mykhaila Hrushevskoho St, 7, Kyiv, 01601, Ukraine.
Ihor StarychenkoUkrainian Public Health Centre of the Ministry of Health of Ukraine, Yaroslavska St, 41, Kyiv, 04071, Ukraine.
Ihor KizinMinistry of Health of Ukraine, Mykhaila Hrushevskoho St, 7, Kyiv, 01601, Ukraine.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to monitor risks of temperature excursions along vaccine distribution routes in Ukraine to identify weaknesses and recommend improvements.

methodsThis cross-sectional study followed the World Health Organization’s temperature monitoring protocol. Vaccine shipments along randomly selected distribution routes were monitored using loggers, recording temperatures at 20 min intervals across all levels of the cold chain. The collected data were analysed to assess compliance with the recommended range and identify instances of heat and freeze exposure.

resultsA total of 72040.1 h were recorded from July 2024 to October 2024 across 48 distribution routes. The recorded temperature ranged from − 13.6 °C to + 28.4 °C. The level of compliance with the recommended temperature range varied by immunisation supply chain level and across facilities at a given level. The highest compliance (~ 100%) was observed at national and oblast stores and during transits between these levels. At the same time, the lowest compliance (88.8%) during storage was observed at primary healthcare centre (PHC) sub-offices, with three of such facilities failing to maintain the recommended range at any point during the study. Additionally, 20 freeze and five heat alarms were recorded at this level, indicative of prolonged exposures. During transits to PHC and sub-offices, compliance was achieved during 54.8% and 60.3% of the recorded time, respectively. Furthermore, eight transits to PHC and 15 to PHC sub-offices failed to maintain temperatures within the required range throughout the transit.

conclusionsWhile Ukraine’s vaccine cold chain system is effective at higher levels, temperature excursions were common at lower levels, particularly in PHC sub-offices and during transport to lower-level facilities. Equipment malfunctions, gaps in knowledge and lack of procedures, compounded by power outages and lack of power supply contingencies, are probable causes. Systematically identifying and documenting temperature excursions and assessing the potential damage to vaccines are recommended immediate actions. Providing further qualified equipment, ensuring resilient power supply, strengthening training, and improving procedures and supervision to prevent and mitigate risks of temperature excursion incidents are longer-term recommended actions. Implementing these actions would strengthen Ukraine’s immunisation supply chain resilience, ensuring safe and effective immunisation services.

Indexed as

Drug StorageRefrigerationTransportationVaccinesCross-Sectional StudiesHumansTemperatureUkraineVaccinesCold chainTemperature monitoringUkraineVaccines

Identifiers

PMID41808080
PMCPMC13088377

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.